Form 4: Edwards Lifesciences Executive Reports Stock Disposal to Cover Tax Obligations
SEC Form 4
Catherine M. Szyman, CVP at Edwards Lifesciences, disposed of 258 shares of common stock on July 7, 2024, to cover tax obligations.
Summary
- On July 7, 2024, Catherine M. Szyman, CVP of Critical Care at Edwards Lifesciences, disposed of 258 shares of common stock.
- The transaction was executed at a price of $92.32 per share.
- This disposal was likely to cover tax obligations related to vesting of stock or option exercise.
- Following the transaction, Szyman directly owns 75,907.4373 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to executive compensation and doesn't indicate any significant positive or negative sentiment towards the company.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. This transaction appears to be a standard tax-related stock disposal, common among executives who receive stock-based compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a small percentage of the total outstanding shares and appears to be related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/07/2024 | Date of stock disposal transaction |
| 07/08/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.